In the present report, we identified for the first time that high ASF1B expression is also associated with poor prognosis in ACC, KIRC, KIRP, LGG, LIHC, MESO, PAAD, and UVM. This evidence concerns the gene ASF1B and pancreatic adenocarcinoma.